American Lung Association: COVID-19 and Emerging Respiratory Viruses Research Award

American Lung Association
COVID-19 and Emerging Respiratory Viruses Research Award
Value: $100k for up to two years
Deadline: May 30, 2020
General Description
There is an urgent need to better understand the pathobiology and clinical implications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection that leads to the morbidity and mortality seen with COVID-19, as well as increase knowledge about the potential emerging threat of other novel respiratory viruses. We are looking for proposals to advance research against emerging respiratory pathogens like SARS-CoV-2. All research must directly be related to COVID-19 or other viral respiratory threats that may arise in the future. The Lung Association is interested in applications that address the following types of clinical, basic, translational, and population health questions:

  • A new understanding of the basic biology of respiratory viruses that could lead to better treatment and prevention
  • Development of novel therapeutics and vaccines
  • Understanding host factors that alter response to these infections
  • Understanding individual, regional, or social factors increasing or decreasing community spread of COVID-19 and other respiratory viruses
  • Case tracking and epidemiological approaches to understanding COVID-19 and other respiratory viruses